Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 147 recruiting studies, sorted by proximity — each links to its official registry page
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Red River Research Partners — Bolivar, Missouri (29.8 mi)
· Sponsor: Incyte Corporation
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Breast Cancer, TNBC - Triple-Negative Breast Cancer
N/A
Observational 900 participants sought
Oncology Hematology Associates — Springfield, Missouri (1.5 mi)
· Sponsor: Tempus AI
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Oncology Hematology Associates — Springfield, Missouri (1.5 mi)
· Sponsor: Eli Lilly and Company
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Mercy Research - Springfield /ID# 262385 — Springfield, Missouri (1.5 mi)
· Sponsor: AbbVie
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Oncology Hematology Associates — Springfield, Missouri (1.5 mi)
· Sponsor: BeOne Medicines
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
Phase 2
Interventional 200 participants sought
GSK Investigational Site — Springfield, Missouri (1.5 mi)
· Sponsor: GlaxoSmithKline
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: Wake Forest University Health Sciences
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
CoxHealth South Hospital — Springfield, Missouri (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Mercy Research — Springfield, Missouri (1.5 mi)
· Sponsor: Novo Nordisk A/S
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Cancer, Immunotherapy
N/A
Observational 2,000 participants sought
Mercy Hospital - SPG — Springfield, Missouri (1.5 mi)
· Sponsor: Elephas
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Springfield, Missouri (1.5 mi)
· Sponsor: Axsome Therapeutics, Inc.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
Triple Negative Breast Cancer
Phase 3
Interventional 657 participants sought
Cox Medical Center — Springfield, Missouri (1.5 mi)
· Sponsor: Jina Pharmaceuticals Inc.
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: University of Rochester
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Red River Research Partners, Llc- Site Number : 8400054 — Bolivar, Missouri (29.8 mi)
· Sponsor: Sanofi
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Angioimmunoblastic T-cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma
Phase 2
Interventional 170 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Clinvest Headlands LLC — Springfield, Missouri (1.5 mi)
· Sponsor: Kallyope Inc.
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
AAA - Abdominal Aortic Aneurysm
N/A
Observational 2,000 participants sought
Cox Health — Springfield, Missouri (1.5 mi)
· Sponsor: W.L.Gore & Associates